Follow-up study of the long-term efficacy and safety of investigator-initiated clinical trials (HUCV002-01-02 study and HUCV002-01-03 study) of intravenous HUCV002-01 in patients with chronic heart failure (HUCV002-01-02 study and HUCV002-01-03 study)
Not Applicable
Recruiting
- Conditions
- chronic heart failureheart failure, cardiomyopathyD006333
- Registration Number
- JPRN-jRCT1070220091
- Lead Sponsor
- Ide Tomomi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1)Patients who voluntarily participated in the preceding investigator-initiated clinical trial (protocol number: Study HUCV002-01-02 or Study HUCV002-01-03) and were administered the investigational product.
2)Patients who has ability to understand and sign the informed consent
Exclusion Criteria
1) Patients whom the PI or investigators decided as inappropriate for the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method